Related Experiment Video

Updated: May 5, 2026

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
08:32

Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates

Published on: February 17, 2023

1.8K

[Clinical features of giardiasis in different age groups of pediatric in-patients]

Pedro Almirall1, Maydel Alfonso, Ivonne Ávila

  • 1Centro Municipal de Higiene, Epidemiología y Microbiología, La Habana, Cuba.

Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia
|November 20, 2013
PubMed

Insights

Clinical features of giardiasis vary by age in children. Younger children (<5 years) more frequently experience diarrhea, while older children (≥5 years) present with abdominal pain and urticaria. Early recognition aids diagnosis and treatment.

Area of Science:

  • Pediatric Infectious Diseases
  • Gastroenterology
  • Parasitology

Background:

  • Giardiasis (caused by Giardia lamblia) is a common parasitic infection.
  • Clinical manifestations of giardiasis may differ across pediatric age groups.

Purpose of the Study:

  • To compare the clinical presentation of giardiasis in children under 5 years old versus those 5 years and older.
  • To analyze the length of hospital stay in relation to age.

Main Methods:

  • Retrospective study of 170 pediatric patients hospitalized with giardiasis in 2007.
  • Comparison of clinical features between two age groups: <5 years and ≥5 years.
  • Analysis of hospital length of stay.

Main Results:

  • Children ≥5 years had significantly higher rates of abdominal pain (OR=9.46) and urticaria (OR=11.0).
  • Children <5 years showed a higher frequency of diarrhea (OR=6.45).
  • Younger children (<5 years) had a significantly longer hospital stay.

Conclusions:

  • Pediatric giardiasis presents with distinct clinical features based on age.
  • Recognizing age-specific symptoms is crucial for timely diagnosis and effective treatment of giardiasis.
Abstract

More Related Videos

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children10:57

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children

Published on: August 22, 2012

23.1K
Author Spotlight: Advancements in Understanding and Combatting Shigella Infections04:56

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections

Published on: February 9, 2024

1.9K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
975
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
413
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
92
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
414
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
1.1K